Survivorship, Version 2.2017: Clinical practice guidelines in oncology

Crystal S. Denlinger, Tara Sanft, K. Scott Baker, Shrujal Baxi, Gregory Broderick, Wendy Demark-Wahnefried, Debra L. Friedman, Mindy Goldman, Melissa Hudson, Nazanin Khakpour, Allison King, Divya Koura, Elizabeth Kvale, Robin M. Lally, Terry S. Langbaum, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Javid J. Moslehi, Tracey O'ConnorLinda Overholser, Electra D. Paskett, Jeffrey Peppercorn, M. Alma Rodriguez, Kathryn J Ruddy, Paula Silverman, Sophia Smith, Karen L. Syrjala, Amye Tevaarwerk, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Deborah A. Freedman-Cass, Nicole R. McMillian

Research output: Contribution to journalReview article

35 Citations (Scopus)

Abstract

Many cancer survivors experience menopausal symptoms, including female survivors taking aromatase inhibitors or with a history of oophorectomy or chemotherapy, and male survivors who received or are receiving androgen-ablative therapies. Sexual dysfunction is also common in cancer survivors. Sexual dysfunction and menopause-related symptoms can increase distress and have a significant negative impact on quality of life. This portion of the NCCN Guidelines for Survivorship provide recommendations for screening, evaluation, and treatment of sexual dysfunction and menopausal symptoms to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period.

Original languageEnglish (US)
Pages (from-to)1140-1163
Number of pages24
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume15
Issue number9
DOIs
StatePublished - Sep 1 2017

Fingerprint

Practice Guidelines
Survivors
Survival Rate
Neoplasms
Aromatase Inhibitors
Ovariectomy
Menopause
Androgens
Quality of Life
Guidelines
Delivery of Health Care
Drug Therapy
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Denlinger, C. S., Sanft, T., Baker, K. S., Baxi, S., Broderick, G., Demark-Wahnefried, W., ... McMillian, N. R. (2017). Survivorship, Version 2.2017: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 15(9), 1140-1163. https://doi.org/10.6004/jnccn.2017.0146

Survivorship, Version 2.2017 : Clinical practice guidelines in oncology. / Denlinger, Crystal S.; Sanft, Tara; Baker, K. Scott; Baxi, Shrujal; Broderick, Gregory; Demark-Wahnefried, Wendy; Friedman, Debra L.; Goldman, Mindy; Hudson, Melissa; Khakpour, Nazanin; King, Allison; Koura, Divya; Kvale, Elizabeth; Lally, Robin M.; Langbaum, Terry S.; Melisko, Michelle; Montoya, Jose G.; Mooney, Kathi; Moslehi, Javid J.; O'Connor, Tracey; Overholser, Linda; Paskett, Electra D.; Peppercorn, Jeffrey; Rodriguez, M. Alma; Ruddy, Kathryn J; Silverman, Paula; Smith, Sophia; Syrjala, Karen L.; Tevaarwerk, Amye; Urba, Susan G.; Wakabayashi, Mark T.; Zee, Phyllis; Freedman-Cass, Deborah A.; McMillian, Nicole R.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 15, No. 9, 01.09.2017, p. 1140-1163.

Research output: Contribution to journalReview article

Denlinger, CS, Sanft, T, Baker, KS, Baxi, S, Broderick, G, Demark-Wahnefried, W, Friedman, DL, Goldman, M, Hudson, M, Khakpour, N, King, A, Koura, D, Kvale, E, Lally, RM, Langbaum, TS, Melisko, M, Montoya, JG, Mooney, K, Moslehi, JJ, O'Connor, T, Overholser, L, Paskett, ED, Peppercorn, J, Rodriguez, MA, Ruddy, KJ, Silverman, P, Smith, S, Syrjala, KL, Tevaarwerk, A, Urba, SG, Wakabayashi, MT, Zee, P, Freedman-Cass, DA & McMillian, NR 2017, 'Survivorship, Version 2.2017: Clinical practice guidelines in oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 15, no. 9, pp. 1140-1163. https://doi.org/10.6004/jnccn.2017.0146
Denlinger CS, Sanft T, Baker KS, Baxi S, Broderick G, Demark-Wahnefried W et al. Survivorship, Version 2.2017: Clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network. 2017 Sep 1;15(9):1140-1163. https://doi.org/10.6004/jnccn.2017.0146
Denlinger, Crystal S. ; Sanft, Tara ; Baker, K. Scott ; Baxi, Shrujal ; Broderick, Gregory ; Demark-Wahnefried, Wendy ; Friedman, Debra L. ; Goldman, Mindy ; Hudson, Melissa ; Khakpour, Nazanin ; King, Allison ; Koura, Divya ; Kvale, Elizabeth ; Lally, Robin M. ; Langbaum, Terry S. ; Melisko, Michelle ; Montoya, Jose G. ; Mooney, Kathi ; Moslehi, Javid J. ; O'Connor, Tracey ; Overholser, Linda ; Paskett, Electra D. ; Peppercorn, Jeffrey ; Rodriguez, M. Alma ; Ruddy, Kathryn J ; Silverman, Paula ; Smith, Sophia ; Syrjala, Karen L. ; Tevaarwerk, Amye ; Urba, Susan G. ; Wakabayashi, Mark T. ; Zee, Phyllis ; Freedman-Cass, Deborah A. ; McMillian, Nicole R. / Survivorship, Version 2.2017 : Clinical practice guidelines in oncology. In: JNCCN Journal of the National Comprehensive Cancer Network. 2017 ; Vol. 15, No. 9. pp. 1140-1163.
@article{d246cb49901a4302b4214b4f57c78b72,
title = "Survivorship, Version 2.2017: Clinical practice guidelines in oncology",
abstract = "Many cancer survivors experience menopausal symptoms, including female survivors taking aromatase inhibitors or with a history of oophorectomy or chemotherapy, and male survivors who received or are receiving androgen-ablative therapies. Sexual dysfunction is also common in cancer survivors. Sexual dysfunction and menopause-related symptoms can increase distress and have a significant negative impact on quality of life. This portion of the NCCN Guidelines for Survivorship provide recommendations for screening, evaluation, and treatment of sexual dysfunction and menopausal symptoms to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period.",
author = "Denlinger, {Crystal S.} and Tara Sanft and Baker, {K. Scott} and Shrujal Baxi and Gregory Broderick and Wendy Demark-Wahnefried and Friedman, {Debra L.} and Mindy Goldman and Melissa Hudson and Nazanin Khakpour and Allison King and Divya Koura and Elizabeth Kvale and Lally, {Robin M.} and Langbaum, {Terry S.} and Michelle Melisko and Montoya, {Jose G.} and Kathi Mooney and Moslehi, {Javid J.} and Tracey O'Connor and Linda Overholser and Paskett, {Electra D.} and Jeffrey Peppercorn and Rodriguez, {M. Alma} and Ruddy, {Kathryn J} and Paula Silverman and Sophia Smith and Syrjala, {Karen L.} and Amye Tevaarwerk and Urba, {Susan G.} and Wakabayashi, {Mark T.} and Phyllis Zee and Freedman-Cass, {Deborah A.} and McMillian, {Nicole R.}",
year = "2017",
month = "9",
day = "1",
doi = "10.6004/jnccn.2017.0146",
language = "English (US)",
volume = "15",
pages = "1140--1163",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "9",

}

TY - JOUR

T1 - Survivorship, Version 2.2017

T2 - Clinical practice guidelines in oncology

AU - Denlinger, Crystal S.

AU - Sanft, Tara

AU - Baker, K. Scott

AU - Baxi, Shrujal

AU - Broderick, Gregory

AU - Demark-Wahnefried, Wendy

AU - Friedman, Debra L.

AU - Goldman, Mindy

AU - Hudson, Melissa

AU - Khakpour, Nazanin

AU - King, Allison

AU - Koura, Divya

AU - Kvale, Elizabeth

AU - Lally, Robin M.

AU - Langbaum, Terry S.

AU - Melisko, Michelle

AU - Montoya, Jose G.

AU - Mooney, Kathi

AU - Moslehi, Javid J.

AU - O'Connor, Tracey

AU - Overholser, Linda

AU - Paskett, Electra D.

AU - Peppercorn, Jeffrey

AU - Rodriguez, M. Alma

AU - Ruddy, Kathryn J

AU - Silverman, Paula

AU - Smith, Sophia

AU - Syrjala, Karen L.

AU - Tevaarwerk, Amye

AU - Urba, Susan G.

AU - Wakabayashi, Mark T.

AU - Zee, Phyllis

AU - Freedman-Cass, Deborah A.

AU - McMillian, Nicole R.

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Many cancer survivors experience menopausal symptoms, including female survivors taking aromatase inhibitors or with a history of oophorectomy or chemotherapy, and male survivors who received or are receiving androgen-ablative therapies. Sexual dysfunction is also common in cancer survivors. Sexual dysfunction and menopause-related symptoms can increase distress and have a significant negative impact on quality of life. This portion of the NCCN Guidelines for Survivorship provide recommendations for screening, evaluation, and treatment of sexual dysfunction and menopausal symptoms to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period.

AB - Many cancer survivors experience menopausal symptoms, including female survivors taking aromatase inhibitors or with a history of oophorectomy or chemotherapy, and male survivors who received or are receiving androgen-ablative therapies. Sexual dysfunction is also common in cancer survivors. Sexual dysfunction and menopause-related symptoms can increase distress and have a significant negative impact on quality of life. This portion of the NCCN Guidelines for Survivorship provide recommendations for screening, evaluation, and treatment of sexual dysfunction and menopausal symptoms to help healthcare professionals who work with survivors of adult-onset cancer in the posttreatment period.

UR - http://www.scopus.com/inward/record.url?scp=85028992405&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028992405&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2017.0146

DO - 10.6004/jnccn.2017.0146

M3 - Review article

C2 - 28874599

AN - SCOPUS:85028992405

VL - 15

SP - 1140

EP - 1163

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 9

ER -